|
 |
INVIRASEThis page contains recent news articles, when available, and an overview of INVIRASE but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: INVIRASE (when available) Saquinavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Saquinavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. HIV-1 with advanced immunodeficiency together with antiretroviral nucleoside analogues Mechanism Of Action: Saquinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. News Articles on Saquinavir Lower Norvir Boosting Dose Possible - Oct 29, 2009 For Invirase, the current approved dose is 1000 mg of Invirase combined with 100 mg of Norvir, taken twice daily. But other dosing strategies have been ... AIDSmeds.com HIV/AIDS Treatment News … to Focus Resources on Availability of Invirase, Now Preferred... - Feb 6, 2006 NUTLEY, NJ -- February 6, 2006 -- Roche today announced that effective February 15, 2006, the company will discontinue the US sale and distribution of ... DG News Europe approves new Invirase 500 mg tablet for the treatment of HIV - May 27, 2005 Roche announced today the European marketing approval for its new 500 mg formulation of Invirase (saquinavir mesylate), an effective and well tolerated ... Medical News Today - Medical News Today (press release) Final Gemini Study Results Confirm Boosted Invirase Was as Effective... - Oct 25, 2007 NUTLEY, NJ -- Final 48-week results from an international head-to-head trial, presented today at the 11th European AIDS Conference (EACS), Madrid, ... Free with registration - Business Wire - AccessMyLibrary.com … Analysis of New Study Suggests Boosted INVIRASE(R) May Achieve … - Nov 13, 2006 NUTLEY, NJ, Nov. 13 /PRNewswire-FirstCall/ -- Encouraging results from an interim analysis of a new study suggest that the boosted protease inhibitor (PI/r) ... Free with registration - PR Newswire - AccessMyLibrary.com Roche drops HIV drug research programme - report - Jul 14, 2008 PK - news - people ) said it will continue to make its Fuzeon, Viracept and Invirase HIV drugs, alongside HIV diagnostics and treatments for conditions ... Forbes New Data Suggest Boosted Invirase(R) has Similar Efficacy to Boosted ... - Jul 20, 2007 NUTLEY, NJ, July 20 /PRNewswire/ -- A new interim analysis of an international, head-to-head trial suggests that HIV patients treated with the protease ... Free with registration - PR Newswire - AccessMyLibrary.com Europe approves new Invirase 500 mg tablet for the treatment of HIV - May 29, 2005 Roche announced the European marketing approval for its new 500 mg formulation of Invirase (saquinavir mesylate), an effective and well tolerated protease ... Medical News Today - Medical News Today (press release) … Results Find That Patients Treated With Boosted INVIRASE, A Potent... - Jul 25, 2005 ..."These data show that early treatment with INVIRASE resulted in an ... The new formulation of INVIRASE, which was approved under a six-month priority ... $4.95 - PR Newswire - ECNext Boosted Invirase (saquinavir) 500 Has Similar Efficacy And An Overall... - Jul 25, 2007 Encouraging 24 week, full cohort head to head results of an international trial demonstrate that HIV-infected patients initiating treatment with the boosted ... Medical News Today - Medical News Today (press release) Chugai to Launch HIV Protease Inhibitor INVIRASE(R) Tablet 500mg on … - Sep 14, 2006 Tokyo, Japan, Sept 14, 2006 - (JCN Newswire) - Chugai Pharmaceutical Co., Ltd. announced today the launch of a new drug for HIV (Human Immunodeficiency ... Free with registration - JCN Newswires - AccessMyLibrary.com Patients treated with boosted Invirase, a potent anti-HIV treatment,... - Jul 28, 2005 Starting treatment of HIV infection with Roche's protease inhibitor Invirase® (saquinavir mesylate) boosted with a small dose of ritonavir is not associated ... Medical News Today - Medical News Today (press release) Norvir/Invirase Go Head-to-Head with Kaletra - Jul 26, 2007 By Tim Horn. Early results from a 48-week clinical trial comparing Norvir(ritonavir)-boosted Invirase (saquinavir) to Kaletra (lopinavir plus ritonavir) ... AIDSmeds.com HIV/AIDS Treatment News … Analysis of New Study Suggests Boosted INVIRASE(R) May Achieve … - Nov 13, 2006 Interim Analysis of New Study Suggests Boosted INVIRASE(R) May Achieve Similar Levels of HIV Suppression to Boosted Lopinavir with a Favorable Lipid ... Pay-Per-View - PR Newswire - HighBeam Research HIV/AIDS Therapy; Invirase receives FDA marketing approval - Jan 17, 2005 2005 JAN 17 - (NewsRx.com & NewsRx.net) -- Roche's new Invirase 500 mg formulation has received US Food and Drug Administration (FDA) marketing approval ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones … Roche to Focus Resources on Availability of INVIRASE(R), Now... - Feb 6, 2006 Roche to Focus Resources on Availability of INVIRASE(R), Now Preferred Formulation of Saquinavir. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research New Data Suggest Boosted Invirase® Has Similar Efficacy to Boosted … - Jul 23, 2007 A new interim analysis of an international, head-to-head trial suggests that HIV patients treated with the protease inhibitor Invirase® 500 (saquinavir ... webwire.com … HIV Treatment Guidelines Recommend Boosted Invirase(R) As A First ... - Nov 20, 2005 New European Guidelines for the Clinical Management and Treatment of HIV Infected Adults published today recommend boosted Invirase(R) (saquinavir mesylate) ... Medical News Today - Medical News Today (press release) … Release: New Study Indicates Boosted Invirase 500 Patients Achieve... - Nov 13, 2006 New Study Indicates Boosted Invirase 500 Patients Achieve Similar Levels of Viral Suppression to Boosted Lopinavir but with a Better Lipid Profile. Pay-Per-View - PR Newswire Europe - HighBeam Research HIV/AIDS Treatment; Invirase boosted with ritonavir not associated... - Aug 24, 2005 2005 AUG 24 - (NewsRx.com) -- Starting treatment of HIV infection with Roche's protease inhibitor Invirase (saquinavir mesylate) boosted with a small dose ... Pay-Per-View - Vaccine Weekly - Factiva, from Dow Jones Roche's Invirase non-inferior to Kaletra. - Nov 5, 2007 Final 48-week results from a head-to-head trial presented today at the 11th European AIDS Conference, held in Madrid, Spain, demonstrated that ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Boosted Invirase vs. Kaletra - Nov 15, 2006 ...by Tim Horn. (AIDSmeds.com)—Early results from a 48-week clinical trial comparing Norvir® (ritonavir)-boosted Invirase® (saquinavir) to Kaletra® (lopinavir ... AIDSmeds.com HIV/AIDS Treatment News Patients treated with boosted Invirase, a potent anti-HIV treatment,... - Jul 30, 2005 Starting treatment of HIV infection with Roche's protease inhibitor Invirase® (saquinavir mesylate) boosted with a small dose of ritonavir is not associated ... i-newswire.com MEDS BETTER THAN GRAPEFRUIT - Mar 25, 2007 ...sertraline (Zoloft), sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), saquinavir (Invirase) and erythromycin (Ery-Tab and others). ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver … HIV Treatment Guidelines Recommend Boosted Invirase(R) as a First ... - Nov 18, 2005 New European HIV Treatment Guidelines Recommend Boosted Invirase(R) as a First Choice Treatment for Patients Starting Therapy. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research International Approvals: Invirase and Remicade - May 15, 2006 May 15, 2006 — Health Canada has approved a 500-mg tablet formulation of saquinavir mesylate that significantly reduces the daily pill count for patients ... Medscape Fewer pills for Invirase.(HIV protease inhibitor)(Brief Article) - Apr 1, 2005 A new 500-mg tablet of the HIV protease inhibitor, Invirase, is now available. Patients taking this new version now only need to take two 500-mg pills twice ... $4.95 - HIV Treatment: ALERTS! - ECNext Philanthropic Roche shares manufacturing technology with Africa - Jun 4, 2007 Roche introduced Invirase (saquinavir) in 1995 and was the world's first HIV ... Invirase and Fortovase (saquinavir) saw a 28 per cent increase to 182m ... In-PharmaTechnologist.com Roche's Invirase 500mg gets US approval.(Brief Article) - Jan 3, 2005 Swiss drugmaker Roche has obtained US Food and Drug Administration approval of a new 500mg film-coated tablet formulation of its HIV protease inhibitor ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Invirase lowers HIV levels with better lipid profile. - Nov 20, 2006 Invirase lowers HIV levels with better lipid profile. Swiss drug major Roche says that data from a study of its protease inhibitor Invirase (saquinavir ... $9.94 - Pharma Marketletter - Alacra Store Invirase (saquinavir, SQV) - Mar 1, 2008 Invirase es un medicamento anti-VIH que pertenece a la categorÃa de los inhibidores de la proteasa (IP). Invirase evita que las células que están infectadas ... AIDSmeds.com HIV/AIDS Treatment News … Release: European Approval for Roche's New Invirase 500 mg Tablet... - May 27, 2005 European Approval for Roche's New Invirase 500 mg Tablet for the Treatment of HIV. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research IAC: HIV Suppressed on Long-Term Boosted-Kaletra Monotherapy - Aug 21, 2006 In three trials, researchers showed that monotherapy with the protease inhibitor Kaletra boosted either with Norvir (ritonavir) or Invirase (saquinavir) ... MedPage Today Le laboratoire Roche suspend sa recherche contre le sida - Jul 15, 2008 Roche continuera de commercialiser trois médicaments destinés au traitement du VIH/sida : le Fuzeon, Viracept et Invirase. Ils ont enregistré des ventes de ... nouvelobs.com Press Release: Roche to Voluntarily Withdraw Anti-HIV Medication … - May 18, 2005 New INVIRASE(R) 500 mg tablet reduces pill count and diminishes clinical demand for ... INVIRASE will remain on the market in both 500 mg tablets and 200 mg ... Pay-Per-View - PR Newswire - HighBeam Research Roche announces transfer of protease inhibitor know-how to 3 African ... - Sep 22, 2006 Roche, the manufacturer of nelfinavir (Viracept) and saquinavir (Invirase), announced today that it has agreed to pass on the know-how to make its protease ... Aidsmap Roche; Invirase receives FDA marketing approval - Jan 19, 2005 2005 JAN 19 - (NewsRx.com & NewsRx.net) -- Roche's new Invirase 500 mg formulation has received US Food and Drug Administration (FDA) marketing approval ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones ARVs 'might help fight malaria' - Oct 10, 2006 They found that serum taken from people who were taking antiretroviral therapy - which included ritonavir-boosted saquinavir (Invirase) or lopinavir ... News24.com Press Release: Patients Treated With Boosted Invirase, a Potent Anti... - Jul 25, 2005 Patients Treated With Boosted Invirase, a Potent Anti-HIV Treatment, Do Not Develop Resistance. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research NRTI-sparing combination of ritonavir-boosted indinavir and efavirenz... - Aug 10, 2006 ...cause such serious metabolic changes such as atazanavir (Reyataz) or saquinavir (Invirase) may be more attractive options for the reversal of fat loss. ... Aidsmap International Approvals: Glumetza, 500-mg Invirase, Proxinium - Jun 6, 2005 June 6, 2005 -- The Canadian Therapeutic Products Directorate has approved a once-daily, extended-release formulation of metformin HCl for the treatment of ... Medscape Saquinavir Side Effects from Consumer Reports Health. - Jan 10, 2005 Invirase® brand hard gelatin capsules and tablets and Fortovase® brand soft ... Invirase must be taken with another medication called ritonavir (Norvir), ... consumerreports.org Roche's new Invirase version OKd in EU.(pharmaceutial industry)(Brief... - Jun 6, 2005 Swiss drug major Roche has obtained European marketing approval for its new 500mg formulation of Invirase (saquinavir mesylate), a protease inhibitor for ... $4.95 - Pharma Marketletter - ECNext Roche Full Year 2004 Results Presentation in London - Part 2. - Feb 2, 2005 Some of them we've talked about, others like the Invirase 500 simplifies the use of Invirase as a PI. Don't write it off as something of yesterday's news. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Europe advocates Invirase use for HIV.(Brief Article) - Nov 28, 2005 New European guidelines for the clinical management and treatment of HIV-infected adults recommends boosted Invirase (saquinavir mesylate), ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Liver toxicity warning.(Invirase or Fortavase with rifampin)(Advertise... - Apr 1, 2005 Patients taking either boosted or unboosted Invirase (saquinavir, hard gel capsules) or Fortavase (saquinavir, soft-gel capsules) should not take rifampin ... $4.95 - HIV Treatment: ALERTS! - ECNext Scriptlines: Invirase.(Brief Article) - May 28, 2005 Invirase 200mg tablets (saquinavir) are now available in a 120-pack size. Used as part of HIV anti-retroviral therapy, the protease inhibitor was previously ... $4.95 - Chemist & Druggist - ECNext Liver toxicity warning.(Invirase or Fortavase with rifampin)(Advertise... - Apr 1, 2005 Liver toxicity warning.(Invirase or Fortavase with rifampin)(Advertisement) ... find HIV Treatment: ALERTS! articles. Patients taking either boosted or ... Pay-Per-View - HIV Treatment: ALERTS! - HighBeam Research Roche gets favourable initial EMEA review for Invirase. - Feb 28, 2005 Roche has received a favourable EMEA review for Invirase 500 mg formulation of saquinavir ... Invirase is usually prescribed in combination with tironavir. ... Pay-Per-View - Chimie Pharma Hebdo - Factiva, from Dow Jones Roche to Pull HIV/AIDS Drug Due to Dwindling Demand - May 18, 2005 A new formulation of Invirase (saquinavir mesylate) has become the preferred ... Invirase will remain on the market in both 500 mg tablets and 200 mg ... Daily News Central OTC: New prescription product: Invirase 500mg.(Roche Products Ltd)( … - Aug 6, 2005 Film-coated tablets containing saquinivir 500mg Usual dose: two tablets twice daily New high strength addition to range Roche Products Ltd. Tel: 0800 731 ... $4.95 - Chemist & Druggist - ECNext Which Are The Easiest Drug Combinations? (A Look At Fewer Pills and … - Aug 17, 2007 Invirase must be used in combination with Norvir. The approved dose is two 500mg Invirase tablets plus one 100mg Norvir capsule, twice a day (a total of 6 ... AIDSmeds.com HIV/AIDS Treatment News Le laboratoire Roche suspend sa recherche contre le sida - Jul 18, 2008 Toutefois Roche continuera de commercialiser trois médicaments destinés au traitement du VIH/sida (Fuzeon, Viracept et Invirase) qui ont enregistré des ... TÊTU Scriptlines: High strength Invirase tabs. - Jun 18, 2005 Previously only available as 200mg capsules, the company says the new 500mg tablet will simplify dosing regimens for patients by reducing the tablet count ... $4.95 - Chemist & Druggist - ECNext Fortovase.(Drug overview) - Jan 22, 2007 The active ingredient in Invirase is saquinavir mesylate, and although it's ... Although they contain a similar ingredient, Fortovase and Invirase are not ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Roche прекращает разработку препаратов длÑ? лечениÑ? ВИЧ-инфекци … - Jul 15, 2008 Ð’ наÑ?тоÑ?щее времÑ? на рынке приÑ?утÑ?твуют три ее препарата длÑ? лечениÑ? ВИЧ-инфекции: «Fuzeon» (Ñ?нфувиртид), «Viracept» (нелфинавир) и «Invirase» (Ñ?аквинавир). ... Sostav.ru Brand Names/Synonyms: INVIRASE is also known by the following brand names and/or synonymsFortovase; Invirase; ROC; SAQUINAVIR; SQV; Saquinavir; Saquinavir Mesylate; Saquinavir [Usan] Drug Category: INVIRASE is categorized under the following by the FDA: Anti-HIV Agents; Anti-HIV Agents; ATC:J05AE01 Dosage Forms: INVIRASE (saquinavir mesylate) capsules and FORTOVASE (saquinavir) soft gelatin capsules Absorption: Absolute bioavailability of saquinavir administered as INVIRASE averaged 4% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: N-[1-benzyl-2-hydroxy-3-[3-(tert-butylcarbamoyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinolin-2-yl]-propyl]-2-quinolin-2-ylcarbonylamino-butanediamide |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |